NCCN's 2026 guidelines recommend routine integration of AI-based 5-year breast cancer risk prediction from mammograms.
Key Details
- 1NCCN updated guidelines to recommend AI-based 5-year breast cancer risk assessment using routine mammograms.
- 2Patients with an AI-predicted 5-year risk ≥1.7% should be considered for supplemental imaging (MRI or ultrasound).
- 3Risk evaluations should begin at age 35, earlier than the previous standard of 40.
- 4Re-assessment over time is advised due to changes in breast tissue.
- 5The Clairity Breast platform, FDA-cleared for this purpose, is highlighted and is reportedly over 3x more accurate at risk prediction than density reporting by radiologists.
Why It Matters
These recommendations will likely accelerate adoption of AI tools in breast imaging, standardizing risk stratification and personalized screening. Radiologists and imaging providers must prepare for new workflows and patient stratification protocols based on AI outputs.
Source
Radiology Business
Related News
•Radiology Business
ACR Expands Resources for Radiology Practices to Assess Imaging AI
The ACR is offering new tools to help radiology practices evaluate and monitor imaging AI algorithms.
•AuntMinnie
FDA Rejects Petition to Exempt Radiology AI Devices from 510(k) Review
FDA denies a petition to exempt certain radiology AI software from 510(k) review, stressing ongoing regulatory oversight.
•AuntMinnie
Study Reveals Women's Willingness to Pay for AI in Mammography
Awareness of AI accuracy, error rates, and advertising affect women's out-of-pocket willingness to pay for AI-supported mammography.